Market Overview

Why Zynex's Stock Is Trading Higher Today

Why Zynex's Stock Is Trading Higher Today

Zynex (NASDAQ: ZYXI) shares are trading higher on Monday after H.C. Wainwright & Co upgraded the stock from Neutral to Buy and announced a price target of $25 per share.

Zynex is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products.

The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. It also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development.

The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave, Non-Invasive Blood Volume Monitor and others.

Zynex shares were trading up 7.04% at $16.58 on Monday during the time of publication. The stock has a 52-week high of $29.73 and a 52-week low of $7.51.

Latest Ratings for ZYXI

Sep 2020HC Wainwright & Co.UpgradesNeutralBuy
Sep 2020Northland Capital MarketsUpgradesMarket PerformOutperform
Jul 2020B. Riley FBRUpgradesNeutralBuy

View More Analyst Ratings for ZYXI
View the Latest Analyst Ratings


Related Articles (ZYXI)

View Comments and Join the Discussion!

Posted-In: why it's movingUpgrades Price Target Analyst Ratings

Latest Ratings

CMGDeutsche BankMaintains1,235.0
AAPLPiper SandlerMaintains135.0
ALGNPiper SandlerMaintains500.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at